Itch E3 Ubiquitin Ligase Positively Regulates TGF-β Signaling to EMT via Smad7 Ubiquitination

  • Park, Su-Hyun (Department of Pharmacology, Yeungnam University College of Medicine) ;
  • Jung, Eun-Ho (Department of Pharmacology, Yeungnam University College of Medicine) ;
  • Kim, Geun-Young (Division of Cardiovascular and Rare Diseases, Center for Biomedical Sciences, Korea National Institute of Health) ;
  • Kim, Byung-Chul (Department of Biochemistry, College of Natural Sciences, Kangwon National University) ;
  • Lim, Jae Hyang (Department of Microbiology, Ewha Womans University School of Medicine) ;
  • Woo, Chang-Hoon (Department of Pharmacology, Yeungnam University College of Medicine)
  • Received : 2014.05.09
  • Accepted : 2014.10.17
  • Published : 2015.01.31


TGF-${\beta}$ regulates pleiotropic cellular responses including cell growth, differentiation, migration, apoptosis, extracellular matrix production, and many other biological processes. Although non-Smad signaling pathways are being increasingly reported to play many roles in TGF-${\beta}$-mediated biological processes, Smads, especially receptor-regulated Smads (R-Smads), still play a central mediatory role in TGF-${\beta}$ signaling for epithelial-mesenchymal transition. Thus, the biological activities of R-Smads are tightly regulated at multiple points. Inhibitory Smad (I-Smad also called Smad7) acts as a critical endogenous negative feedback regulator of Smad-signaling pathways by inhibiting R-Smad phosphorylation and by inducing activated type I TGF-${\beta}$ receptor degradation. Roles played by Smad7 in health and disease are being increasingly reported, but the molecular mechanisms that regulate Smad7 are not well understood. In this study, we show that E3 ubiquitin ligase Itch acts as a positive regulator of TGF-${\beta}$ signaling and of subsequent EMT-related gene expression. Interestingly, the Itch-mediated positive regulation of TGF-${\beta}$ signaling was found to be dependent on Smad7 ubiquitination and its subsequent degradation. Further study revealed Itch acts as an E3 ubiquitin ligase for Smad7 polyubiquitination, and thus, that Itch is an important regulator of Smad7 activity and a positive regulator of TGF-${\beta}$ signaling and of TGF-${\beta}$-mediated biological processes. Accordingly, the study uncovers a novel regulatory mechanism whereby Smad7 is controlled by Itch.




Supported by : Korean Ministry of Health & Welfare, Korean National Research Foundation


  1. Bai, Y., Yang, C., Hu, K., Elly, C., and Liu, Y.C. (2004). Itch E3 ligase-mediated regulation of TGF-beta signaling by modulating smad2 phosphorylation. Mol. Cell 15, 825-831.
  2. Derynck, R., and Akhurst, R.J. (2007). Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat. Cell Biol. 9, 1000-1004.
  3. Fang, D., Elly, C., Gao, B., Fang, N., Altman, Y., Joazeiro, C., Hunter, T., Copeland, N., Jenkins, N., and Liu, Y.C. (2002). Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. Nat. Immunol. 3, 281-287.
  4. Ho, K.C., Zhou, Z., She, Y.M., Chun, A., Cyr, T.D., and Yang, X. (2011). Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected]. Proc. Natl. Acad. Sci. USA 108, 4870-4875.
  5. Kavsak, P., Rasmussen, R.K., Causing, C.G., Bonni, S., Zhu, H., Thomsen, G.H., and Wrana, J.L. (2000). Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol. Cell 6, 1365-1375.
  6. Kwon, A., Lee, H.L., Woo, K.M., Ryoo, H.M., and Baek, J.H. (2013). SMURF1 plays a role in EGF-induced breast cancer cell migration and invasion. Mol. Cells 36, 548-555.
  7. Lallemand, F., Seo, S.R., Ferrand, N., Pessah, M., L'Hoste, S., Rawadi, G., Roman-Roman, S., Camonis, J., and Atfi, A. (2005). AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanism. J. Biol. Chem. 280, 27645-27653.
  8. Lohr, N.J., Molleston, J.P., Strauss, K.A., Torres-Martinez, W., Sherman, E.A., Squires, R.H., Rider, N.L., Chikwava, K.R., Cummings, O.W., Morton, D.H., et al. (2010). Human ITCH E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease. Am. J. Hum. Genet. 86, 447-453.
  9. Perry, W.L., Hustad, C.M., Swing, D.A., O'Sullivan, T.N., Jenkins, N.A., and Copeland, N.G. (1998). The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice. Nat. Genet. 18, 143-146.
  10. Rossi, M., Aqeilan, R.I., Neale, M., Candi, E., Salomoni, P., Knight, R.A., Croce, C.M., and Melino, G. (2006). The E3 ubiquitin ligase Itch controls the protein stability of p63. Proc. Natl. Acad. Sci. USA 103, 12753-12758.
  11. Salah, Z., Melino, G., and Aqeilan, R.I. (2011). Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity. Cancer Res. 71, 2010-2020.
  12. Schwarz, S.E., Rosa, J.L., and Scheffner, M. (1998). Characterization of human hect domain family members and their interaction with UbcH5 and UbcH7. J. Biol. Chem. 273, 12148-12154.
  13. Shi, Y., and Massague, J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700.
  14. Su, J., and Liu, Y.C. (2010). Foxp3 positive regulatory T cells: a functional regulation by the E3 ubiquitin ligase Itch. Semin. Immunopathol. 32, 149-156.
  15. Venuprasad, K., Huang, H., Harada, Y., Elly, C., Subramaniam, M., Spelsberg, T., Su, J., and Liu, Y.C. (2008). The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1. Nat. Immunol. 9, 245-253.
  16. Wei, W., Li, M., Wang, J., Nie, F., and Li, L. (2012). The E3 ubiquitin ligase ITCH negatively regulates canonical Wnt signaling by targeting dishevelled protein. Mol. Cell. Biol. 32, 3903-3912.
  17. Woo, C.H., Shishido, T., McClain, C., Lim, J.H., Li, J.D., Yang, J., Yan, C., and Abe, J. (2008). Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells. Circ. Res. 102, 538-545.
  18. Wood, J.D., Yuan, J., Margolis, R.L., Colomer, V., Duan, K., Kushi, J., Kaminsky, Z., Kleiderlein, J.J., Sharp, A.H., and Ross, C.A. (1998). Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins. Mol. Cell. Neurosci. 11, 149-160.
  19. Zhang, S., Fei, T., Zhang, L., Zhang, R., Chen, F., Ning, Y., Han, Y., Feng, X.H., Meng, A., and Chen, Y.G. (2007). Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol. Cell. Biol. 27, 4488-4499.

Cited by

  1. E3 ubiquitin ligase: A potential regulator in fibrosis and systemic sclerosis vol.306-307, 2016,
  2. The roles of ubiquitin modifying enzymes in neoplastic disease 2017,
  3. The ubiquitin ligase Smurf2 suppresses TGFβ-induced epithelial–mesenchymal transition in a sumoylation-regulated manner vol.23, pp.5, 2016,
  4. Selective multifaceted E3 ubiquitin ligases barricade extreme defense: Potential therapeutic targets for neurodegeneration and ageing vol.24, 2015,
  5. ASPP2 suppresses invasion and TGF-β1-induced epithelial–mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer vol.398, 2017,
  6. SMAD3/Stat3 Signaling Mediates β-Cell Epithelial-Mesenchymal Transition in Chronic Pancreatitis–Related Diabetes vol.66, pp.10, 2017,
  7. Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy vol.31, pp.1, 2017,
  8. Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer? pp.1476-5594, 2018,